AAPL 192.14 -3.2 (-1.64%)MSFT 117.58 -2.46 (-2.05%)FB 164.73 -1.32 (-0.79%)ZNGA 5.3 -0.13 (-2.31%)NVDA 177.26 -6.63 (-3.61%)WBA 62.56 -1.01 (-1.59%)GOOG 1205.94 -25.16 (-2.04%)PIH 5.45 -0.16 (-2.85%)
AAPL 192.14 -3.2 (-1.64%)MSFT 117.58 -2.46 (-2.05%)FB 164.73 -1.32 (-0.79%)ZNGA 5.3 -0.13 (-2.31%)NVDA 177.26 -6.63 (-3.61%)WBA 62.56 -1.01 (-1.59%)GOOG 1205.94 -25.16 (-2.04%)PIH 5.45 -0.16 (-2.85%)

Cash Flow ABMD Quote ABIOMED Inc

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
NetIncome 38 52 112
Depreciation 3 6 11
DeferredIncomeT 22 26 43
StockBasedCompe 29 33 40
AccountsReceiva -11 -12 -15
InventoryCS -11 -12 -16
AccountsPayable -3 8 4
OtherWorkingCap 2 2 4
OtherNonCashIte -3 -10 1
NetCashProvided 77 115 193
InvestmentsInPP -16 -50 -56
AcquisitionsNet 0 0 0
PurchasesOfInve -262 -281 -332
SalesMaturities 220 205 207
PurchasesOfInta 0 0 0
OtherInvestingA 0 0 0
NetCashUsedForI -58 -126 -181
DebtIssued 0 0 0
DebtRepayment 0 0 -1
CommonStockIssu 0 0 0
CommonStockRepu 0 0 0
DividendPaid 0 0 0
OtherFinancingA 4 -8 -9
NetCashProvided 7 4 -9
NetChangeInCash 26 -9 4
CashAtBeginning 22 48 39
CashAtEndOfPeri 48 39 43
ABIOMED Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes ABIOMED Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.